ASHEVILLE, N.C. – Cutaneous adhesives have many advantages in dermatologic surgery, according to Dr. John West of Seaport Dermatology and Mohs Surge... More »
MANCHESTER, U.K. – Although around half of patients with refractory systemic lupus erythematous (SLE) benefit from rituximab treatment at 6 months, ... More »
ASHEVILLE, N.C. – Building bridges with colleagues in other specialties, especially primary care, helps patients and improves relations among specia... More »
ASHEVILLE, N.C. – The incidence of leukocytoclastic vasculitis in the general population is 1.5 to 3 times higher than previously reported, based on... More »
MANCHESTER, U.K. – Tocilizumab showed signs of improving skin and other symptoms in patients with systemic sclerosis (SSc) in an ongoing proof-of-co... More »
MANCHESTER, U.K. – Tocilizumab showed signs of improving skin and other symptoms in patients with systemic sclerosis (SSc) in an ongoing proof-of-co... More »
SAN FRANCISCO – The younger people are when they get a tattoo, the more likely they are to regret it later, according to a survey of 501 people in t... More »
SAN FRANCISCO – More than 80% of psoriasis patients who received ixekizumab achieved a 75% reduction in the Psoriasis Area and Severity Index score ... More »
SAN FRANCISCO – Voriconazole increased the risk of squamous cell carcinoma by 73% in a review of 455 lung transplant patients at the University of C... More »
SAN FRANCISCO – Voriconazole increased the risk of squamous cell carcinoma by 73% in a review of 455 lung transplant patients at the University of C... More »